Pay in 4 interest-free payments of $6.60 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
For volume measurements, the DTC was selected and its volume was pulled from the statistic tab
Access, Cost and Shifting Landscape As people on these agents meet their weight and diabetes goals, there is concern that insurance companies will reduce or stop coverage given the high price tag of lifelong incretin therapy
To determine the dissociation constant (K d ) of FHD with p53 TAD PEP, we mixed 10 nM FITC-labeled p53 TAD PEP with increasing concentrations of FHD
Despite the benefits of GLP-1 receptor agonists, affordability and insurance coverage limitations remain critical barriers in some regions, which could potentially hinder widespread adoption
US$ 22.82
US$ 22.75
US$ 27.67
US$ 22.54
US$ 27.94
